Inhibition of phosphorylated protein eIF4E (phospho-elF4E) has shown inhibition of MDSCs and their immunosuppressive effects, a potential future immunotherapy target for the treatment of melanoma progression [39]. This evidence concerns the gene EIF4E and melanoma.